-
Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer
Meek, J. M., van Luijk, I. F., Gorris, M. A. J., Coens, C., Martynova, E., van Ee, T. J., Casado, A., van Doorn, H. C., Vergote, I., de Vries, I. J. M., Kenter, G. G. & Ottevanger, P. B., 5 Oct 2026, In: Eur. J. Cancer. 246, 116984.Research output: Contribution to Journal › Article › Academic › peer-review
-
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994
Kenter, G. G., Greggi, S., Vergote, I., Katsaros, D., Kobierski, J., van Doorn, H., Landoni, F., van der Velden, J., Reed, N., Coens, C., van Luijk, I., Colombo, N., Steen-Banasik, E. V. D., Ottevanger, N. & EORTC-55994 Study Group, 10 Nov 2023, In: Journal of Clinical Oncology. 41, 32, p. 5035-5043 9 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment
van Luijk, I. F., Smith, S. M., Marte Ojeda, M. C., Oei, A. L., Kenter, G. G. & Jordanova, E. S., 1 May 2022, In: Journal of clinical medicine. 11, 9, 2277.Research output: Contribution to Journal › Review article › Academic › peer-review
- All publications
